Moderna, Inc. (LON: 0A45)

Market Cap	12.03B
Revenue (ttm)	3.79B
Net Income (ttm)	-1.66B
Shares Out	n/a
EPS (ttm)	-4.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,355
Average Volume	58,372
Open	35.85
Previous Close	35.58
Day's Range	35.30 - 37.89
52-Week Range	28.46 - 135.35
Beta	1.69
RSI	47.56
Earnings Date	Feb 27, 2025

About Moderna

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vac...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 5,600
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A45

Financial Performance

Financial numbers in USD